Akso Health (AHG) Fundamental Analysis: Revenue, Earnings & Valuation

0.93 / 10

Underperform

Fundamental analysis rates AHG as Underperform with a 0.9/10 score. Fixed‑asset turnover is high (915, modestly positive), but total‑asset turnover, cash‑flow per share and operating cash‑flow ratios are all negative, indicating strained liquidity and earnings potential.

Analysis Checks(2/6)

Net cash flow from operating activities per share (YoY growth rate %)

Value-77.00

Score1/3

Weight20.08%

1M Return-2.44%

Net cash flow from operating activities / Operating revenue (%)

Value7.97

Score0/3

Weight45.59%

1M Return-7.26%

Net cash flow from operating activities (YoY growth rate %)

Value-12.88

Score1/3

Weight17.92%

1M Return-2.30%

Fixed assets turnover ratio

Value915.15

Score2/3

Weight5.23%

1M Return-0.66%

Net cash flow from operating activities / Total liabilities (%)

Value0.07

Score2/3

Weight-22.63%

1M Return2.34%

Total assets turnover ratio

Value0.08

Score0/3

Weight33.82%

1M Return-4.65%

Is AHG fundamentally strong?

AHG scores 0.93/10 on fundamentals and holds a Premium valuation at present. Backed by its -0.64% ROE, -917.77% net margin, -14.90 P/E ratio, 10.20 P/B ratio, and -661.90% earnings growth, these metrics solidify its Underperform investment rating.